Dutas
developed to alleviate symptoms of prostatic enlargement and to target androgen-dependent hormone changes.
Strengths: 0.5mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Avodart
- Therapeutic class
5-Alpha Reductase Inhibitor
- Pharmacological class
5-Alpha Reductase Inhibitor
- Known off-label uses
androgenetic alopecia
- Contraindications
use in women; use in children
- Minor side effects
impotence; decreased libido; ejaculation disorders; gynaecomastia
- Moderate side effects
breast tenderness; skin rash
- Serious side effects
allergic reaction — requires immediate medical attention
- Dosage forms
Capsule, soft
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Dr. Reddy's Laboratories
- Onset Time
3–6 months
- Duration
long term
- Storage instructions
Store at room temperature away from moisture.
- Drug interactions
CYP3A4 inhibitors
- Age restrictions
For adult use only; contraindicated in children.
Precautions and warnings
men should not donate blood while taking and for six months after cessation; women of childbearing age must not handle leaking capsules
Patient summary
developed to alleviate symptoms of prostatic enlargement and to target androgen-dependent hormone changes.
Mechanism of action
Inhibits both type 1 and type 2 5-alpha-reductase isoenzymes, preventing the conversion of testosterone to dihydrotestosterone, which contributes to prostate shrinkage.
Pregnancy and breastfeeding
Pregnancy: Must not be handled by pregnant women due to risk of abnormal genital development in male foetuses. Breastfeeding: No data.
Dutas
developed to alleviate symptoms of prostatic enlargement and to target androgen-dependent hormone changes.
Editorial Notes
- Active ingredient(s): Dutasteride
- Listed indication(s): Benign Prostatic Hyperplasia
Available option
- 30 tablets - 0.5 mg502-0-5-mg-13640